Synnovation Therapeutics: Funding, Investors & Team (Sep 2026)
Synnovation Therapeutics is an oncology company that specializes in developing small molecule treatments designed to specifically target the underlying causes of cancers. With a strong emphasis on improving the lives of cancer patients, the company combines its extensive knowledge in medicinal chemistry, cancer biology, and patient-centric precision medicine to create a variety of innovative targeted therapies. The ultimate mission is to expedite these treatments into clinical trials with the purpose of revolutionizing cancer care.
Synnovation Therapeutics has raised $40.0M across 2 funding rounds on record, the most recent an undisclosed round of $15.0M announced in Dec 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Synnovation Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Synnovation Therapeutics Funding Rounds
Synnovation Therapeutics raised $25.0M in an undisclosed round announced in May 2023.
7 months later, an undisclosed round of $15.0M was announced in Dec 2023.
Synnovation Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Synnovation Therapeutics Funding Compared to Other Biotechnology Startups
Synnovation Therapeutics' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Synnovation Therapeutics in Biotechnology and Wilmington
Companies Similar to Synnovation Therapeutics
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Synnovation Therapeutics Funding FAQs
What does Synnovation Therapeutics do?
Synnovation Therapeutics is an oncology company that specializes in developing small molecule treatments designed to specifically target the underlying causes of cancers. With a strong emphasis on improving the lives of cancer patients, the company combines its extensive knowledge in medicinal chemistry, cancer biology, and patient-centric precision medicine to create a variety of innovative targeted therapies. The ultimate mission is to expedite these treatments into clinical trials with the purpose of revolutionizing cancer care.
How much funding has Synnovation Therapeutics raised?
Synnovation Therapeutics has raised $40.0M across 2 rounds on record. The most recent is an undisclosed round of $15.0M announced in Dec 2023.
When did Synnovation Therapeutics last raise funding?
Synnovation Therapeutics' most recent funding round on record is an undisclosed round of $15.0M, announced in Dec 2023.
Who founded Synnovation Therapeutics?
FundedIQ lists Wenqing Yao (Founder) at Synnovation Therapeutics.
Where is Synnovation Therapeutics headquartered?
Synnovation Therapeutics is based in Wilmington, Delaware, United States.
How many employees does Synnovation Therapeutics have?
Synnovation Therapeutics is in the 11-50 employee band.
How does Synnovation Therapeutics' funding compare to other Biotechnology startups?
Synnovation Therapeutics' latest round of $15.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Synnovation Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Synnovation Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.